SCHEMBL9533770

SCHEMBL9533770

COc1cccc2c1CC(NCCCCCNS(=O)(=O)c1ccc(F)cc1)CC2

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.53
DRD3 P35462 4/20 0.53
HTR1D P28221 1/20 0.52
DRD4 P21917 2/20 0.50
HTR1A P08908 1/20 0.50
ADRA1D P25100 1/20 0.50
ADRA1A P35348 1/20 0.50
ADRA1B P35368 1/20 0.50
MTNR1A P48039 5/20 0.49
MTNR1B P49286 5/20 0.49
MEN1 O00255 1/20 0.49
ALDH1A1 P00352 1/20 0.49
PKM P14618 1/20 0.49
KMT2A Q03164 1/20 0.49
CYP1A2 P05177 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47
ALOX15 P16050 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9243922 0.99 DRD2 (0.52) DRD2DRD3HTR1DDRD4HTR1A
SCHEMBL9239130 0.84 MTNR1A (0.46) DRD2DRD3HTR1DDRD4HTR1A
Hydrochloric Acid SCHEMBL9242599 0.83 MTNR1A (0.46) DRD2DRD3HTR1DDRD4HTR1A
SCHEMBL8969041 0.82 CHRM2 (0.51) DRD2DRD3DRD4HTR1AADRA1D
SCHEMBL9239204 0.80 DRD2 (0.65) DRD2DRD3DRD4MTNR1AMTNR1B
Hydrochloric Acid SCHEMBL9242418 0.79 DRD2 (0.63) DRD2DRD3DRD4MTNR1AMTNR1B
SCHEMBL8894131 0.77 DRD2 (0.83) DRD2DRD3HTR1DDRD4MTNR1A
Hydrochloric Acid SCHEMBL9241618 0.76 MTNR1A (0.46) HTR1AMTNR1AMTNR1BCYP1A2MAPT
SCHEMBL8970546 0.75 DRD2 (0.43) DRD2DRD3DRD4HTR1AADRA1D
SCHEMBL9534218 0.75 MTNR1A (0.52) DRD2DRD3DRD4HTR1AADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5153225-A For treating disorders of the central nervous system, cardiovascular system and intestinal tract BAYER AKTIENGESELLSCHAFT (DE) 1992-10-06 US claimed
EP-0270947-B1 SUBSTITUTED BASIC 2-AMINOTETRALINES BAYER AG (DE) 1993-05-19 EP disclosed
EP-0270947-A2 Substituted basic 2-aminotetralines BAYER AG (DE) 1988-06-15 EP disclosed